Reyoung Pharmaceutical is an API manufacturer based in China. It holds 9 active US drug master files across a filed portfolio of 9 molecules. Its filings concentrate with ARCSA (EC), DIGEMAPS (DO) and FDA (GH). Its GMP standing is certified by ANVISA (Brazil), MFDS (Korea) and INVIMA (CO), among 7 authorities.
| Site | FDA FEI |
|---|---|
| SHANDONG, China | Not on file |
| Zibo, China | Not on file |
| Shandong, Colombia | Not on file |
| Shandong Province, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Aripiprazole | US FDA | 1 |
| Avanafil | US FDA | 1 |
| Avatrombopag | US FDA | 1 |
| Azilsartan Medoxomil | US FDA | 1 |
| Dapoxetine | US FDA | 1 |
| Moxifloxacin | US FDA | 1 |
| Rilpivirine | US FDA | 1 |
| Tenofovir Alafenamide | US FDA | 1 |
| Topiroxostat | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 79 | None |
| DIGEMAPS (DO) | 56 | None |
| FDA (GH) | 47 | 1 |
| NAFDAC (NG) | 40 | 1 |
| MINSA (CR) | 31 | None |
| EFDA (ET) | 25 | None |
| ANVISA (Brazil) | None | 4 |
| MFDS (Korea) | None | 2 |
| INVIMA (CO) | None | 2 |
| EMA | None | 2 |
| UZPHARM (UZ) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Reyoung Pharmaceutical comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.